Ivana Sullivan

13PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCellular immunologyMolecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 23, 2025
Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial.

Mariano Provencio, Begoña Campos, María Guirado

|May 14, 2025
CD274 (PD-L1) Polymorphisms as Predictors of Efficacy in First-Line Platinum-Based Chemotherapy for Extensive-Stage Small Cell Lung Cancer.

Andrés Barba, Laura López-Vilaró, Malena Ferre

|Sep 28, 2024
ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer.

Andrés Barba, Laura López-Vilaró, Malena Ferre

|May 25, 2024
Potential Role of Circulating PD-L1+ Leukocytes as a Predictor of Response to Anti-PD-(L)1 Therapy in NSCLC Patients.

Georgia Anguera, Maria Mulet, Carlos Zamora

|May 11, 2024
Kinetics of IFNγ-Induced Cytokines and Development of Immune-Related Adverse Events in Patients Receiving PD-(L)1 Inhibitors.

Leticia Alserawan, Maria Mulet, Geòrgia Anguera

|Feb 16, 2024
EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers.

Marco Tagliamento, Marie Morfouace, Charalambos Loizides

Pageof 3

Frequent Collaborators

5 joint publications

Margarita Majem Tarruella

3 joint publications

Silvia Vidal

2 joint publications

Rubén Osuna-Gómez

2 joint publications

Juliana Salazar